Scientific reviews and scores are in for CIRM’s Disease Team III RFA. We don’t know the identifies of the applicants yet, but 3 out of 4 of the top scoring grants recommended outright for funding are focused on cancer. As a cancer stem cell researcher (and cancer survivor) I’m excited to see how well these […]
Cancer Grants Perform Well With CIRM Disease Team Reviews Read More »
Yesterday I posted a list of a dozen potential candidates to be considered for the position of the new CIRM President. To be clear, that list is not my list. It is also not CIRM’s list and I’m sure that CIRM’s Search Committee has its own ideas of course. The list in yesterday’s post was
Some More Thoughts on the Search for a New CIRM President Read More »
Who might make a fantastic new CIRM President? The California stem cell community is abuzz with this question. This new President will not only lead CIRM today, but also in all likelihood will steer CIRM in its new incarnation after 2017, what I’ve called CIRM 2.0. At least that would be ideal. CIRM has posted a
Dozen Candidates To Be New CIRM President Read More »
The current President of the California Institute for Regenerative Medicine (CIRM), Dr. Alan Trounson, will be leaving the agency in the near future to have more time with his family back in Australia. As a result, CIRM will need a new President at a critical juncture in its history with only about 4 years of
CIRM Presidential Search Committee Formed to Pick New Leader Read More »
What does the future hold for the California Institute for Regenerative Medicine (CIRM), also known as the California Stem Cell Agency? While new CIRM grants should be awarded up until 2017, CIRM is rightly thinking about its future. Californians should be paying attention and thinking ahead too. You might say that since I’m a CIRM
The Case for CIRM 2.0: Continuing California’s Stem Cell Leadership Read More »
Alan Trounson, President of CIRM and CIRM itself both announced late this afternoon that Trounson will be leaving the California Stem Cell Agency. Trounson is leaving CIRM to spend more time with his family, who are literally located around the world in Australia. In an email to the CIRM community, Trounson said: “I need to
CIRM President Trounson To Leave the Agency Read More »
Duane Roth, the Vice-Chair of the California Stem Cell Agency CIRM and the leader of CONNECT, an organization promoting entrepreneurship in the San Diego area, died yesterday. Roth had been in a serious solo cycling accident on July 21. Roth had a long, successful career in biotech including having founded Alliance Pharmaceutical Corp. He was
Tribute to CIRM Vice-Chair, Duane Roth Read More »
CIRM recently held an “elevator pitch” (also sometimes known as an “elevator speech”) contest amongst its grantees. The San Francisco Chronicle even covered this contest (and also here). Kevin McCormack, Sr. Director of Public Communications and Patient Advocate Outreach at CIRM, described the contest in, appropriately enough, a speech. As best as I can tell 56 scientists participated. By way
My top 3 favorite CIRM elevator pitches Read More »
CIRM has indicated that the Institute of Medicine (IOM) recommended that CIRM provide funding for training and research on ethics and regulatory issues. In response to this recommendation and with the perspectives of various “CIRM funded researchers and other experts”, CIRM has responded with a new ethics & regulatory recommendation document. I have read it
CIRM Ethics & Regulatory Steps: highly responsive to IOM Read More »
Allan Robins of Viacyte (pictured at left–sorry for the fuzzy image) and Paul Simmons of Mesoblast presented this morning at the CIRM Grantee Meeting. Both talks were outstanding. Robins went first. He started by saying how Viacyte had a productive pre-IND meeting with the FDA last year. I believe a target for them is to
Viacyte & Mesoblast present at CIRM Meeting Read More »